166 related articles for article (PubMed ID: 21181129)
1. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.
de Menezes GB; Coutinho ES; Fontenelle LF; Vigne P; Figueira I; Versiani M
Psychopharmacology (Berl); 2011 May; 215(1):1-11. PubMed ID: 21181129
[TBL] [Abstract][Full Text] [Related]
2. Second-generation antidepressants for preventing seasonal affective disorder in adults.
Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study.
Asakura S; Tajima O; Koyama T
Int J Neuropsychopharmacol; 2007 Apr; 10(2):263-74. PubMed ID: 16573847
[TBL] [Abstract][Full Text] [Related]
4. Second-generation antidepressants for seasonal affective disorder.
Thaler K; Delivuk M; Chapman A; Gaynes BN; Kaminski A; Gartlehner G
Cochrane Database Syst Rev; 2011 Dec; (12):CD008591. PubMed ID: 22161433
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
[TBL] [Abstract][Full Text] [Related]
6. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
Baldwin D; Bobes J; Stein DJ; Scharwächter I; Faure M
Br J Psychiatry; 1999 Aug; 175():120-6. PubMed ID: 10627793
[TBL] [Abstract][Full Text] [Related]
9. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
Baldwin DS; Stein DJ; Dolberg OT; Bandelow B
Hum Psychopharmacol; 2009 Jun; 24(4):269-75. PubMed ID: 19334042
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
Schutters SI; Van Megen HJ; Van Veen JF; Denys DA; Westenberg HG
Int Clin Psychopharmacol; 2010 Sep; 25(5):302-4. PubMed ID: 20715300
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.
Hansen RA; Gaynes BN; Gartlehner G; Moore CG; Tiwari R; Lohr KN
Int Clin Psychopharmacol; 2008 May; 23(3):170-9. PubMed ID: 18408531
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis: aerobic exercise for the treatment of anxiety disorders.
Bartley CA; Hay M; Bloch MH
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():34-9. PubMed ID: 23643675
[TBL] [Abstract][Full Text] [Related]
14. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.
Stein DJ; Kasper S; Andersen EW; Nil R; Lader M
Depress Anxiety; 2004; 20(4):175-81. PubMed ID: 15643634
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
Donovan MR; Glue P; Kolluri S; Emir B
J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan.
Asakura S; Hayano T; Hagino A; Koyama T
Curr Med Res Opin; 2016; 32(4):749-57. PubMed ID: 26808688
[TBL] [Abstract][Full Text] [Related]
19. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.
Mallery L; MacLeod T; Allen M; McLean-Veysey P; Rodney-Cail N; Bezanson E; Steeves B; LeBlanc C; Moorhouse P
BMC Geriatr; 2019 Nov; 19(1):306. PubMed ID: 31718566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
